Lifco Ab header image

Lifco Ab

LIFCO B

Equity

ISIN SE0015949201 / Valor 111355378

NASDAQ Nordic Exchange Stockholm, Equities (2024-09-18)
SEK 325.00-1.81%

Lifco Ab
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Lifco Ab is a company that provides a secure environment for small and medium-sized businesses. The company's main business concept is to acquire and enhance market-leading niche businesses that have the potential for sustainable earnings growth and strong cash flows. Lifco operates with a long-term perspective on its holdings, prioritizing profitability and maintaining a decentralized organizational structure. The company has three main business areas: Dental, Demolition & Tools, and Systems Solutions, with a presence in 31 countries through its 233 operating companies. In 2023, Lifco reported an EBITA margin of 23.2% on net sales of SEK 24.4 billion.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (23.05.2024):

Summary of Financial Performance

Lifco AB reported a slight increase in net sales of 0.8% to SEK 6,006 million in the first quarter of 2024, compared to SEK 5,959 million in the same period last year. However, organic net sales saw a decline of 7.8%, primarily due to weaker performance in the Demolition & Tools and parts of the Systems Solutions segments. EBITA decreased by 3.9% to SEK 1,278 million, and the EBITA margin dropped by 1.0 percentage point to 21.3%. Profit before tax also declined by 11.0% to SEK 941 million.

CEO's Commentary

Per Waldemarson, President and CEO of Lifco AB, commented on the first quarter results of 2024, noting the challenges faced due to a weak market in specific segments. Despite these challenges, Lifco AB managed to achieve a net sales increase through strategic acquisitions. The early Easter in 2024, compared to a later Easter in 2023, also slightly impacted the financial results, particularly in the Dental segment.

Operational Cash Flow

Cash flow from operating activities for Lifco AB decreased by 13.6% in the first quarter of 2024, amounting to SEK 631 million compared to SEK 731 million in the previous year. This decline reflects the lower earnings and adjusted working capital movements during the period.

Acquisitions and Financial Position

In the first quarter of 2024, Lifco AB announced the acquisition of two Italian companies, Brevetti Montolit and CFR, which are expected to enhance the company's portfolio in the Demolition & Tools and Systems Solutions segments, respectively. Lifco AB also issued two unsecured bonds totaling SEK 1,000 million, maintaining a strong financial position with interest-bearing net debt at 1.0 times EBITDA.

Segment Performance: Dental

The Dental segment of Lifco AB saw a 2.8% increase in net sales to SEK 1,568 million in the first quarter of 2024. Despite this growth, EBITA slightly decreased by 0.3% to SEK 327 million, and the EBITA margin contracted by 0.6 percentage points to 20.9%. The segment continues to be a significant contributor to Lifco's portfolio, providing a range of products and services to the dental industry across Europe and the US.

Summarized from source with an LLMView Source

Key figures

64.1%1Y
26.5%3Y
243%5Y

Performance

23.6%1Y
32.6%3Y
34.4%5Y

Volatility

Market cap

13584 M

Market cap (USD)

Daily traded volume (Shares)

200,388

Daily traded volume (Shares)

1 day high/low

332.8 / 323.6

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.83%CHF 268.40
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.01%CHF 98.04
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.71%CHF 81.58
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.47%CHF 125.85
Sonova Holding Ltd.
Sonova Holding Ltd. Sonova Holding Ltd. Valor: 1254978
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.29%CHF 295.00
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.86%CHF 73.75
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%CHF 278.40
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%CHF 72.90
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.61%CHF 1.52
Siegfried Holding Ltd
Siegfried Holding Ltd Siegfried Holding Ltd Valor: 1428449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.17%CHF 1,160.00